Blood purification could tackle COVID-19?

被引：0
作者：
Hiroyuki Yamada
Shigeru Ohtsuru
机构：
[1] Kyoto University,Department of Primary Care and Emergency Medicine, Graduate School of Medicine
[2] Kyoto University,Department of Nephrology, Graduate School of Medicine
来源：
Journal of Intensive Care | / 9卷
关键词：
Plasmapheresis; Plasma exchange; Cytosorb; Apheresis; AN69ST; Oxiris; PMX-DHP; Coronavirus; Pandemic; Cytokine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Coronavirus disease 2019 (COVID-19) threatened human lives worldwide since first reported. The current challenge for global intensivists is to establish an effective treatment for severe COVID-19. Blood purification has been applied to the treatment of various critical illnesses. Theoretically, its technique also has an enormous possibility of treating severe COVID-19 in managing inflammatory cytokines and coagulopathy. Recent clinical studies have revealed the positive clinical effect of therapeutic plasma exchange. Other studies have also indicated the considerable potential of other blood purification techniques, such as Cytosorb, AN69 surface-treated membrane, and polymyxin b hemoperfusion. Further research is needed to elucidate the actual effects of these applications.
引用
收藏
相关论文
共 292 条
[1]  
Alhazzani W(2021)Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update Crit Care Med 8 1100-1115
[2]  
Evans L(2021)Japanese Rapid/Living recommendations on drug management for COVID-19 Acute Med Surg 41 483-495
[3]  
Alshamsi F(2020)Mechanisms of SARS-CoV-2 transmission and pathogenesis Trends Immunol 26 171-354
[4]  
Møller MH(2020)COVID-19: epidemiology, evolution, and cross-disciplinary perspectives Trends Mol Med 34 e181-e183
[5]  
Ostermann M(2019)Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue J Clin Apher 8 481-218
[6]  
Prescott HC(2020)The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure SAGE Open Med Case Rep 190 492-202
[7]  
Arabi YM(2020)Efficacy of therapeutic plasma exchange in severe COVID-19 patients Br J Haematol 24 214-178
[8]  
Loeb M(2020)Plasma exchange in critically ill COVID-19 patients Crit Care 99 196-e112
[9]  
Ng Gong M(2020)Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: a retrospective study Medcine (Baltimore) 24 172-762
[10]  
Fan E(2020)Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study Crit Care 16 108-e70
12345678910